Quick answer
Wegovy and Zepbound are both FDA approved for chronic weight management, which makes them the two most direct competitors in this category, but they are different drugs. Wegovy is semaglutide, a GLP-1 agonist. Zepbound is tirzepatide, a dual GIP and GLP-1 agonist. In studied populations, tirzepatide has generally produced larger average weight reductions than semaglutide, but averages are not promises, and the right choice depends on your medical history, tolerability, and insurance. Both are prescription medications requiring physician supervision, and individual results vary.
What Is the Difference Between Wegovy and Zepbound?
The difference is the active ingredient and mechanism. Wegovy contains semaglutide, which acts on the GLP-1 receptor. Zepbound contains tirzepatide, which acts on both the GIP and GLP-1 receptors, making it a dual agonist. Both are FDA approved specifically for chronic weight management, unlike their cousins Ozempic and Mounjaro, which are approved for type 2 diabetes. So this is a true same-category comparison.
Because both target weight management, the choice is less about diagnosis and more about mechanism, tolerability, cost, and response. The dual mechanism of tirzepatide is the central structural difference, and it is the reason the two are studied and discussed separately even though both are weekly injections titrated up slowly.
Is Zepbound More Effective Than Wegovy for Weight Loss?
On average, in clinical studies, tirzepatide has produced larger weight reductions than semaglutide, including in a head-to-head trial. That is the honest summary of the evidence. But "more effective on average" is not the same as "better for you." Average results hide a wide range of individual responses, and factors like the dose reached, side-effect tolerance, adherence, and your health picture all shape the outcome.
This matters because picking a drug purely on a trial average can lead to disappointment or to tolerating side effects unnecessarily. A prescriber weighs the evidence against your history, your insurance, and how you respond. Individual results vary, and neither drug guarantees a specific number. For the full four-way landscape, see our guide on which GLP-1 is right for you.
Do Wegovy and Zepbound Have Different Side Effects?
The side-effect categories are similar because both are incretin-based: most commonly nausea, vomiting, diarrhea, constipation, and reduced appetite, especially at the start and during dose increases. Some people tolerate one better than the other, but there is no reliable rule about which is gentler. Both are started low and titrated up slowly to limit gastrointestinal side effects, and most effects ease as the body adjusts.
Both carry the same boxed warning about thyroid C-cell tumors seen in rodent studies and similar contraindications, so a prescriber screens your personal and family history before starting either. For a deeper look at managing these, see our guide on GLP-1 side effects.
How Do Cost and Insurance Affect the Choice?
Cost and coverage are often the deciding factor, because both are weight-management drugs and many insurance plans cover weight-management medications inconsistently or not at all. Manufacturer savings programs, prior-authorization rules, and your specific plan can make one far more affordable than the other for you, regardless of which performs better on paper. This is why two people with similar goals can end up on different drugs.
The practical move is to have a prescriber and your plan sort out coverage and out-of-pocket cost alongside the clinical comparison, rather than choosing in the abstract. Ascend's medical weight loss program evaluates the clinical fit and works through what is realistic for your situation.
Care at Ascend: Learn more about Weight Loss at Ascend Mind and Body, or book an appointment.
Frequently asked questions
Can I switch from Wegovy to Zepbound?
Sometimes, and it is a prescriber's decision. Because they are different drugs with different mechanisms and dosing, switching is not a direct dose match; your clinician restarts titration appropriately and monitors response. People switch for tolerability, effectiveness, or insurance reasons, but never without medical guidance.
Do I need a prescription for Wegovy or Zepbound in Florida?
Yes. Both are prescription medications in Florida and across the United States. A licensed clinician must evaluate you, confirm you meet the criteria for weight management, and supervise treatment with monitoring and follow-up. There is no legitimate way to obtain either without a prescription.
Can I get a GLP-1 prescription for weight loss by telehealth in Florida?
Often, yes. Florida law allows a licensed clinician to establish care and prescribe by telehealth when the evaluation meets the standard of care. Whether Wegovy or Zepbound is appropriate, and whether it can be started remotely, depends on your history and labs. Ascend evaluates this case by case.
Which is cheaper, Wegovy or Zepbound?
It depends entirely on your insurance, any manufacturer savings programs you qualify for, and prior-authorization outcomes. List prices and coverage change, so there is no fixed answer. Confirm current pricing and coverage with your plan and the clinic, and treat affordability as part of the clinical decision rather than separate from it.
Medically reviewed by
Dr. Jason Saylor, DO
This article is for general educational purposes only and is not medical advice. It does not create a provider-patient relationship. Talk with a qualified Florida-licensed clinician about your individual situation.
Sources
- U.S. Food and Drug Administration. Zepbound (tirzepatide) injection prescribing information. accessdata.fda.gov.
- U.S. Food and Drug Administration. Wegovy (semaglutide) injection prescribing information. accessdata.fda.gov.
- Aronne LJ, et al. Tirzepatide as Compared with Semaglutide for the Treatment of Obesity. New England Journal of Medicine. 2025. nejm.org.